These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25455605)
1. New possibility for providing protection against urinary tract infection caused by Pseudomonas aeruginosa by non-adjuvanted flagellin 'b' induced immunity. Sabharwal N; Chhibber S; Harjai K Immunol Lett; 2014 Dec; 162(2 Pt B):229-38. PubMed ID: 25455605 [TBL] [Abstract][Full Text] [Related]
2. Divalent flagellin immunotherapy provides homologous and heterologous protection in experimental urinary tract infections in mice. Sabharwal N; Chhibber S; Harjai K Int J Med Microbiol; 2016 Jan; 306(1):29-37. PubMed ID: 26655680 [TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581 [TBL] [Abstract][Full Text] [Related]
4. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis. Faezi S; Sattari M; Mahdavi M; Roudkenar MH Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model. Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242 [TBL] [Abstract][Full Text] [Related]
6. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [TBL] [Abstract][Full Text] [Related]
7. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa. Saini H; Vadekeetil A; Chhibber S; Harjai K Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194 [No Abstract] [Full Text] [Related]
8. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model. Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422 [TBL] [Abstract][Full Text] [Related]
9. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa. Weimer ET; Ervin SE; Wozniak DJ; Mizel SB Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586 [TBL] [Abstract][Full Text] [Related]
10. Pseudomonas quinolone signalling system: a component of quorum sensing cascade is a crucial player in the acute urinary tract infection caused by Pseudomonas aeruginosa. Bala A; Chhibber S; Harjai K Int J Med Microbiol; 2014 Nov; 304(8):1199-208. PubMed ID: 25240873 [TBL] [Abstract][Full Text] [Related]
11. Anti-flagellin IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound murine models in a non-type-specific mode. Ahmadi TS; Mousavi Gargari SL; Talei D Mol Immunol; 2021 Aug; 136():118-127. PubMed ID: 34130152 [TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection. Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361 [TBL] [Abstract][Full Text] [Related]
13. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. Saini H; Chhibber S; Harjai K Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277 [TBL] [Abstract][Full Text] [Related]
14. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models. Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582 [TBL] [Abstract][Full Text] [Related]
15. Immunization with Bivalent Flagellin Protects Mice against Fatal Behrouz B; Hashemi FB; Fatemi MJ; Naghavi S; Irajian G; Halabian R; Imani Fooladi AA J Immunol Res; 2017; 2017():5689709. PubMed ID: 29201922 [No Abstract] [Full Text] [Related]
16. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Campodónico VL; Llosa NJ; Grout M; Döring G; Maira-Litrán T; Pier GB Infect Immun; 2010 Feb; 78(2):746-55. PubMed ID: 19995892 [TBL] [Abstract][Full Text] [Related]
18. Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein. Scavone P; Umpiérrez A; Rial A; Chabalgoity JA; Zunino P Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1139-48. PubMed ID: 24771125 [TBL] [Abstract][Full Text] [Related]
19. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection. Habibi M; Asadi Karam MR; Bouzari S Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195 [TBL] [Abstract][Full Text] [Related]
20. Multiple virulence factors regulated by quorum sensing may help in establishment and colonisation of urinary tract by Pseudomonas aeruginosa during experimental urinary tract infection. Gupta P; Gupta RK; Harjai K Indian J Med Microbiol; 2013; 31(1):29-33. PubMed ID: 23508426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]